Capital Advisors Ltd. LLC Grows Position in The Cooper Companies, Inc. (NASDAQ:COO)

Capital Advisors Ltd. LLC boosted its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 304.0% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 400 shares of the medical device company’s stock after purchasing an additional 301 shares during the quarter. Capital Advisors Ltd. LLC’s holdings in Cooper Companies were worth $41,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the stock. Vanguard Group Inc. grew its stake in Cooper Companies by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 5,732,473 shares of the medical device company’s stock worth $2,169,397,000 after buying an additional 56,911 shares during the period. Congress Asset Management Co. MA increased its holdings in shares of Cooper Companies by 252.4% in the 1st quarter. Congress Asset Management Co. MA now owns 1,263,754 shares of the medical device company’s stock worth $128,220,000 after acquiring an additional 905,173 shares during the period. Victory Capital Management Inc. increased its holdings in shares of Cooper Companies by 16.5% in the 4th quarter. Victory Capital Management Inc. now owns 995,245 shares of the medical device company’s stock worth $376,641,000 after acquiring an additional 140,700 shares during the period. Norges Bank acquired a new stake in shares of Cooper Companies in the 4th quarter worth about $196,045,000. Finally, Handelsbanken Fonder AB increased its holdings in shares of Cooper Companies by 6.0% in the 4th quarter. Handelsbanken Fonder AB now owns 383,722 shares of the medical device company’s stock worth $145,216,000 after acquiring an additional 21,568 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Stock Up 0.1 %

Shares of NASDAQ COO traded up $0.12 during mid-day trading on Tuesday, reaching $86.51. The company had a trading volume of 665,394 shares, compared to its average volume of 1,106,126. The stock has a fifty day moving average of $92.65 and a two-hundred day moving average of $94.80. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.14 and a current ratio of 1.95. The company has a market capitalization of $17.23 billion, a price-to-earnings ratio of 50.74, a PEG ratio of 2.16 and a beta of 0.98. The Cooper Companies, Inc. has a 12-month low of $75.93 and a 12-month high of $104.07.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, May 30th. The medical device company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.02. The firm had revenue of $942.60 million for the quarter, compared to analyst estimates of $948.07 million. Cooper Companies had a net margin of 9.11% and a return on equity of 8.87%. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.77 earnings per share. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 3.57 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Friday, May 31st. JPMorgan Chase & Co. upgraded shares of Cooper Companies from a “neutral” rating to an “overweight” rating and increased their target price for the company from $100.00 to $120.00 in a research report on Wednesday, March 13th. Citigroup increased their target price on shares of Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Robert W. Baird increased their target price on shares of Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a research report on Friday, May 31st. Finally, Redburn Atlantic upgraded shares of Cooper Companies from a “neutral” rating to a “buy” rating and set a $125.00 target price for the company in a research report on Tuesday, March 19th. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $111.42.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.